CUREator Incubator Fuels Biotech with $1.865M Funding
Posted: 11 September 2024 CUREator, Australia’s national biotech incubator managed by Brandon BioCatalyst, today announced that four companies will receive top-up funding across their Preclinical and Health Security streams. Top-up funding rounds are supplemented with monies from projects…
AusBiotech appoints Industry Growth Program Manager
Posted: 11 September 2024 AusBiotech is pleased to announce the appointment of Tamlyn O’Connor as its new Industry Growth Program Manager. Tamlyn will deliver AusBiotech’s ‘Innovation Activation Program’ for Australian biotech and medtech SMEs that are part of…
First Patient Enters DMX-200 Open Label Extension Study After Successfully Completing ACTION3 Phase 3 Trial
Posted: 10 September 2024 Dimerix Limited (ASX: DXB), a biopharmaceutical company with a Phase 3 clinical asset in kidney disease, today announced that the first patient has successfully completed the ACTION3 Phase 3 clinical trial, including the initial…
PAT-DX1 GMP specification testing update
Posted: 4 September 2024 Patrys Limited a therapeutic antibody development company, provides the following update regarding the recently completed GMP manufacturing run of PAT-DX1. Patrys’ Contract Development Manufacturing Organization (CDMO) has advised the Company that specification testing using…
NUKED – a special investigation into the radiopharmaceuticals industry
Posted: 4 September 2024 Debuting at number four on Apple Podcasts Australia in the Life Sciences category, the Phase III podcast is now sharing its second deep-dive series on the sector. The NUKED series explores the growth in…
Man who could save Australia’s koalas honoured with Qld life science award
Posted: 4 September 2024 The creator of a vaccine that has the potential to prevent Australia’s koala population being decimated by chlamydia has been awarded a top biotechnology award in a ceremony in Brisbane on Friday. Professor Peter…
Significant results from new brain cancer drugs as Chroma platform matures
Posted: 4 September 2024 Innovative biotech company Noxopharm Limited (ASX:NOX) is pleased to announce substantial progress on its Chroma™ technology platform, with encouraging brain cancer results plus early work on leukaemia. Glioblastoma is the most frequent and lethal…
Blood test can help predict chronic lung disease in preterm babies
Posted: 3 September 2024 A blood test can help predict which preterm babies will go onto develop chronic lung disease, allowing for earlier diagnosis and more targeted treatments, according to a new study. The research, led by Murdoch…
Blood stem cell breakthrough could transform bone marrow transplants
Posted: 3 September 2024 Melbourne researchers have made a world first breakthrough into creating blood stem cells that closely resemble those in the human body. And the discovery could soon lead to personalised treatments for children with leukaemia…
MTPConnect Backs Start-ups In Heart Disease and Diabetes through New $28.5M TTRA Investment
Posted: 3 September 2024 MTPConnect will inject much-needed funding and support for Australian small to medium enterprises (SMEs) to commercialise innovative medical products to better treat cardiovascular disease and diabetes when it rolls out new investment through its…
New funds to Embrace rare genetic disorder research
Posted: 3 September 2024 Scientists at La Trobe University have received nearly $140,000 from rare disease charity Archie’s Embrace to investigate an under-researched genetic disorder which causes early-onset neurodegeneration in babies. The disorder, which causes a deficiency of…
Non-invasive testing a way of the future
Posted: 3 September 2024 A new collaborative study between the RMH and WEHI is the latest technology to test for early markers of kidney rejection via a simple urine test, hoping to bypass the need for invasive biopsies. Researchers at the RMH and WEHI are…
